Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Oral prodrug of ganciclovir for CMV treatment and prevention. | IV antiviral for CMV infection in transplant and HIV patients. |
| Body system | Antivirals | Antivirals |
| Drug class | Nucleoside analogues (herpes) | Nucleoside analogues (herpes) |
| Supply | Prescription only | Prescription only |
| Main uses | CMV prevention after transplant, CMV retinitis, Congenital CMV (specialist) | CMV retinitis, CMV disease in transplant recipients, CMV prevention after transplant |
| How it works | Stops cytomegalovirus from multiplying. | Stops cytomegalovirus from multiplying. |
| Starts working | Days | Days |
| Half-life | About 4 hours | 2–4 hours |
| Typical adult dose | 900 mg twice a day for induction, then 900 mg once a day for maintenance or prevention. | 5 mg/kg IV every 12 hours for induction, then once daily for maintenance. |
| Forms | Tablet, Oral solution | IV infusion |
| Common side effects | Diarrhoea, Nausea, Low white cells, Headache | Fever, Low blood counts, Nausea, Diarrhoea |
| Serious side effects | Severe neutropenia and anaemia, Low platelets, Seizures, Birth defects | Severe neutropenia and anaemia, Low platelets, Seizures, Birth defects |
| Don't take if | Very low blood counts; Pregnancy; Breastfeeding | Very low neutrophil or platelet counts; Pregnancy; Allergy to aciclovir (cross-reactivity) |
| Alcohol | Best to limit. Alcohol may worsen nausea. | Usually no problem in moderation. Not directly relevant. |
| Pregnancy | Usually avoidedHarmful to the baby. | Usually avoidedHarmful to the baby; avoid unless life-threatening. |
| Breastfeeding | Usually avoidedAvoid. | Usually avoidedAvoid. |
| In use since | — | — |
| Brand names | United States: ValcyteUnited Kingdom: ValcyteIndia: Valcyte, Valcyt | United States: CytoveneUnited Kingdom: CymeveneIndia: Cytovene, Ganciclovir (generic) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H |
| ATC code | J05AB14 | J05AB06 |
Taken together
- ModerateValganciclovir + Ganciclovir: Added bone marrow suppression
Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.